Authors/Disclosures
|
Allan J. MacKenzie-Graham, PhD, BS
(University of California, Los Angeles)
|
No disclosure on file |
|
Jay H. Levin, MD
(Cooley Dickinson Hospital)
|
No disclosure on file |
|
Marco Pisa, MD
(Nuffield Department of Clinical Neurosciences, University of Oxford)
|
Dr. Pisa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Giovanni DiMaggio
|
No disclosure on file |
|
|
No disclosure on file |
|
Lucia Moiola, MD, PhD
(Fondazione Centro San Raffaele)
|
Dr. Moiola has nothing to disclose. |
|
|
No disclosure on file |
|
Vittorio Martinelli
(S. Raffaele Hospital)
|
Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Melanie Martin
|
No disclosure on file |
|
Letizia M. Leocani, MD
(University Vita-Salute San Raffaele, INSPE)
|
Dr. Leocani has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche . Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Med-ex learning. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Rhonda Voskuhl, MD
(UCLA)
|
Dr. Voskuhl has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for CleopatraRX. Dr. Voskuhl has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for CleopatraRX. Dr. Voskuhl has or had stock in CleopatraRX. The institution of Dr. Voskuhl has received research support from NIH. The institution of Dr. Voskuhl has received research support from Conrad N Hilton Foundation. Dr. Voskuhl has received intellectual property interests from a discovery or technology relating to health care. |
|
Arthur Toga
(UCLA School of Medicine)
|
No disclosure on file |